Stromal factors involved in prostate carcinoma metastasis to bone.
about
Activation of an olfactory receptor inhibits proliferation of prostate cancer cellsThe membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cellsIdentification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cellsChanges in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancerBMPs and their clinical potentialsThrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cellsPI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cellsThe IL sequence in the LLKIL motif in CXCR2 is required for full ligand-induced activation of Erk, Akt, and chemotaxis in HL60 cells.Hypoxic tumor microenvironments reduce collagen I fiber densityCullin-1 promotes cell proliferation via cell cycle regulation and is a novel in prostate cancer.The Yin and Yang of bone morphogenetic proteins in cancer.Probing the interaction forces of prostate cancer cells with collagen I and bone marrow derived stem cells on the single cell level.Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genisteinDetection and isolation of circulating tumor cells in urologic cancers: a reviewCombination of rapamycin, CI-1040, and 17-AAG inhibits metastatic capacity of prostate cancer via Slug inhibition.Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo.Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1.Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer.The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell nichesImaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells.Regulatory T cells in the bone marrow microenvironment in patients with prostate cancerA novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model.Elastase release by transmigrating neutrophils deactivates endothelial-bound SDF-1alpha and attenuates subsequent T lymphocyte transendothelial migrationExtracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation.Interactions between microenvironment and cancer cells in two animal models of bone metastasisProteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.Tissue microarrays of human tumor xenografts: characterization of proteins involved in migration and angiogenesis for applications in the development of targeted anticancer agents.Cancer to bone: a fatal attraction.The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites.Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.NF-kappaB regulates androgen receptor expression and prostate cancer growth.Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α.A novel role of Shc adaptor proteins in steroid hormone-regulated cancers.Imaging metastatic bone disease from carcinoma of the prostateExpression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer.Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology.Thrombin expression in prostate: a novel finding.False-positive diagnosis of disease progression by magnetic resonance imaging for response assessment in prostate cancer with bone metastases: A case report and review of the pitfalls of images in the literature
P2860
Q24318917-FAD4B26E-9377-47EE-AC14-456CB932AB67Q24534541-705208F8-8767-4072-9458-3F0EF4B939CAQ24546102-85EBBC02-78ED-4E1E-8052-CD85728A9293Q24807354-33B05AEF-547F-4F55-AABE-AE29CF639C48Q26824827-44F6CA80-B0F4-4421-8C9F-C0531ECBE4D9Q28261735-DD9843F6-102F-4B0D-80C1-4CAE31DD11AEQ28395725-CF0AA243-3EA3-4152-A85F-2F7F65406240Q30496865-82E21368-C13B-4733-9268-EEEDBD4C1E4DQ34041303-06062F2D-E4F2-414D-9BDE-10CC7678AD27Q34043994-3270E108-B813-426E-BF1C-1244B73B78B5Q34127207-12C6DEFC-1C92-41C6-A432-376C5D7EC2E3Q34614433-3EB296F8-7420-4D5F-8827-8E596735D859Q34770095-D2878D28-690F-4BBA-A9FB-35C9FB78A659Q34770149-03CA5A55-9799-46B7-A970-021B36C5DE71Q35018858-F78A4E7A-3E57-4284-A167-F03E1F6821E9Q35060303-BA2AD352-0FDE-4B34-A4A4-4183813BB27CQ35083529-3595A797-CF74-4482-ACBD-CEDD5F9318A0Q35256725-31A1459B-EB49-4F53-9F13-B52C41D9B406Q35499809-AE4D482C-474D-4E1B-9B57-7F73DA53DBEEQ35956405-9F78472C-0AE7-41E6-914B-2A8D8B515E67Q36012911-575EE631-9BED-4648-BB53-91D40D0C18D7Q36038429-17BAF117-0AB2-4317-8B05-B9041E51BD66Q36108572-A9676649-5210-42AE-A952-FD830325E9E6Q36147503-5F4EF0E1-2463-4C9A-8886-C15430ED447BQ36399707-F8D891BF-4BFD-46D7-9904-04706F2C5AB1Q36411158-4A1A242F-AF1D-4F39-9D94-AE304FE93163Q36484558-AC42B2F0-3DCC-4B2A-B636-E9A67CF7712AQ36707418-9F5AD92A-E2F0-4029-837A-EBCF7549ABC5Q36870047-5BCD3FC4-7CE0-4D37-862C-A664183FF07AQ36884628-2A39EA01-6FBA-4716-A166-AE03E8CC1EA0Q37096553-36BAA6E7-9538-4ECE-9124-17EEA5953C89Q37131738-FE29282F-3EFC-4A49-8216-93F1CCF32167Q37278416-6D52DF7F-8918-4409-B4D1-6ADDBA29197BQ37293992-8D2D304C-C8BD-4B82-851E-04F15E1B23B2Q37323041-796E69F0-3240-4900-AA0E-BF56586B3759Q37605543-47F0F7A4-92BC-469E-853F-442A7A1B1D04Q37766499-69A6F63B-DB8A-4540-BBA3-62DA935C0766Q38367417-A15CEE7D-93A6-414A-84EB-AE5CD766C54DQ38413090-4417AF06-5393-482D-8D04-8F90797CF8BBQ38703685-5F9EE4F0-2F64-4C1F-8A12-5007D6BC38A6
P2860
Stromal factors involved in prostate carcinoma metastasis to bone.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Stromal factors involved in prostate carcinoma metastasis to bone.
@ast
Stromal factors involved in prostate carcinoma metastasis to bone.
@en
type
label
Stromal factors involved in prostate carcinoma metastasis to bone.
@ast
Stromal factors involved in prostate carcinoma metastasis to bone.
@en
prefLabel
Stromal factors involved in prostate carcinoma metastasis to bone.
@ast
Stromal factors involved in prostate carcinoma metastasis to bone.
@en
P2093
P356
P1433
P1476
Stromal factors involved in prostate carcinoma metastasis to bone.
@en
P2093
Carlton R Cooper
Christopher H Chay
Evan T Keller
Hyung-Lae Lee
James D Gendernalik
Jasmine Bhatia
Kenneth J Pienta
Laurie K McCauley
P304
P356
10.1002/CNCR.11181
P407
P433
P577
2003-02-01T00:00:00Z